Since elevated numbers of macrophages in association with tumor growth stagnation and regression have been observed in previous studies [28,37], the present model and application scheme could be combined with using a modified CDV, which delivers a functional granulocyte–macrophage colony-stimulating factor (GM-CSF) for an enhanced effect [40]. The gene discussed is CSF2; the disease is neoplasm.